Evidence map›Paper›PMID 40546717›Full record

ArticleCase reports in oncology

Entrectinib-Induced Pericarditis with Cardiac Tamponade in a Patient with Neurotrophic Tropomyosin Receptor Kinase 1 Fusion-Positive Breast Cancer.

Aki Aoyama, Yutaro Yoshitomi, Akihiko Shimomura, Yukino Kawamura, Tomoko Taniyama, Atsumasa Kurozumi, Shuji Kubota, Yukio Hiroi, Chikako Shimizu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aki AoyamaDepartment of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Yutaro YoshitomiDepartment of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Akihiko ShimomuraDepartment of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Yukino KawamuraDepartment of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Tomoko TaniyamaDepartment of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Atsumasa KurozumiDepartment of Cardiology, National Center for Global Health and Medicine, Tokyo, Japan.
Shuji KubotaDepartment of Cardiology, National Center for Global Health and Medicine, Tokyo, Japan.
Yukio HiroiDepartment of Cardiology, National Center for Global Health and Medicine, Tokyo, Japan.
Chikako ShimizuDepartment of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Entrectinib is a multikinase inhibitor used to treat neurotrophic tropomyosin receptor kinase ( Case Presentation: A 31-year-old female with Conclusion: To our knowledge, this is the first reported case of entrectinib-induced pericarditis complicated by cardiac tamponade. Patients should be closely monitored for signs of pericarditis and cardiac tamponade at the start of entrectinib therapy. In patients who develop cardiovascular toxicity due to entrectinib, larotrectinib may be considered as an alternative treatment.

Indexed as

Breast cancerCardiac tamponadeEntrectinibNeurotrophic tropomyosin receptor kinase fusion-positive breast cancerPericarditis

Identifiers

PMID40546717
PMCPMC12180791

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.